The olfactory system is extremely connected to the gustatory system, and at an evolutionary level, the appetite stimulation is elicited by drivers connected to cross-modal and multisensory trigger. The most recent technological tools now allow both to reconstruct in the laboratory sophisticated odors, and to administer the same smells through olfactometers interfaced with neuroimaging instruments. The purpose of this presentation will be to illustrate, through a neurodevelopmental approach, several studies carried out to evaluate both Olfactory Event Related Potentials and gamma variation to olfactory responses, presenting odorous stimuli with edible and non-edible characteristics and associating these parameters with metabolic (i.e, Body Mass Index and neuroendocrine regulators) and dietary characteristics of the subjects, to evaluate how the olfactory guided behaviour can exist. Data will be presented regarding studies conducted with a new patented olfactory device, the US2017127971 (A1), on Obstructive Sleep Apnea Subjects, Mild Cognitive Impairment, healthy adults and newborns and newborns the 3 M syndrome (a rare disease).
Olfactory Assessment and new technologies : a neuro-developmental approach with implication for metabolic health
Sara Invitto
;
2018-01-01
Abstract
The olfactory system is extremely connected to the gustatory system, and at an evolutionary level, the appetite stimulation is elicited by drivers connected to cross-modal and multisensory trigger. The most recent technological tools now allow both to reconstruct in the laboratory sophisticated odors, and to administer the same smells through olfactometers interfaced with neuroimaging instruments. The purpose of this presentation will be to illustrate, through a neurodevelopmental approach, several studies carried out to evaluate both Olfactory Event Related Potentials and gamma variation to olfactory responses, presenting odorous stimuli with edible and non-edible characteristics and associating these parameters with metabolic (i.e, Body Mass Index and neuroendocrine regulators) and dietary characteristics of the subjects, to evaluate how the olfactory guided behaviour can exist. Data will be presented regarding studies conducted with a new patented olfactory device, the US2017127971 (A1), on Obstructive Sleep Apnea Subjects, Mild Cognitive Impairment, healthy adults and newborns and newborns the 3 M syndrome (a rare disease).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
